Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study (Q44596602)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 January 2012
edit
Language Label Description Also known as
English
Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study
scientific article published on 11 January 2012

    Statements

    Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study (English)
    0 references
    0 references
    0 references
    0 references
    Marc Maes
    Jean-Claude Carel
    Séverine Henrard
    Muriel Thomas
    Gladys Zandwijken
    11 January 2012
    E213-7

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit